Edgestream Partners, L.P. Ionis Pharmaceuticals Inc Transaction History

Edgestream Partners, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$42.03 - $53.55 $741,661 - $944,943	17,646 New	17,646 $764,000
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $1.02 Million - $1.27 Million	27,393 New	27,393 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $1.05 Million - $1.27 Million	-31,262 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$34.54 - $47.25 $1.08 Million - $1.48 Million	31,262 New	31,262 $1.25 Million

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.16B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.